Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07479745
PHASE1

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Sponsor: Grünenthal GmbH

View on ClinicalTrials.gov

Summary

The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019

Official title: An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019 in Healthy Male Participants

Key Details

Gender

MALE

Age Range

30 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-03-25

Completion Date

2026-06-06

Last Updated

2026-04-09

Healthy Volunteers

Yes

Interventions

DRUG

[14C]GRT6019

Single administration in a single dosing period.

Locations (1)

Quotient Sciences

Nottingham, United Kingdom